About this trial
This study aims to utilize non-invasive brain-computer interface technology in conjunction with mirror therapy to design a new paradigm for rehabilitation robots to induce compensatory movements on the healthy side in stroke patients, evaluate the potential rehabilitation value of this paradigm for patients with severely impaired motor areas on the affected side, explore the neural rehabilitation compensation mechanism, and provide more personalized rehabilitation treatment strategies for patients with post-stroke motor dysfunction.
Eligibility criteria
Qualifiers
Aged 30 to 80 years
Patients with unilateral upper limb motor dysfunction caused by primary ischemic/hemorrhagic stroke within 1 to 6 months prior to enrollment
Cerebral magnetic resonance diffusion-weighted imaging (DWI) at the time of onset indicating that the stroke lesion is limited to the unilateral basal ganglia region
Modified Rankin Scale (mRS) score of 0 to 2 before stroke onset
Disqualifiers
Patients with other severe cardiovascular and cerebrovascular diseases and unstable vital signs
Patients with motor dysfunction caused by other etiologies, such as amyotrophic lateral sclerosis, myasthenia gravis, muscular dystrophy, hypokalemic periodic paralysis, spondylitis, arthritis, osteomyelitis, etc.
Patients with severe diseases of the lungs, liver, kidneys and other vital organs
Patients with limb movement impairment caused by diseases such as fractures and arthritis
Trial design
Treatments tested in this trial
- Brain computer interface-robotic mirror therapy